Biohaven Ltd. ( BHVN) - Key Metrics
BHVN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.91 | -$0.56 | -$0.57 |
| 2026Q1 | $0 | -$0.88 | -$1.02 | -$1.02 |
| 2025Q4 | $0 | -$1.21 | -$1.09 | -$1.09 |
| 2025Q3 | $0 | -$1.64 | -$1.38 | -$1.38 |
| 2025Q2 | $0 | -$1.94 | -$1.64 | -$1.64 |
BHVN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -4.09 |
| 2026Q1 | 0% | -2.40 |
| 2025Q4 | 0% | -2.33 |
| 2025Q3 | 0% | -2.29 |
| 2025Q2 | 0% | -1.82 |
BHVN
Price: $14.64
52 week price:
Earnings Per Share: -4.55 USD
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 704100
Ebitda: -42.6 millionMarket Capitalization: 2.2 billion